Neonatal Hearing Screening 2009 Europe

Preview:

DESCRIPTION

This presentation describes the importance of neonatal hearing screening, ie. to check if babies can hear. Only if babies are checked and diagnosed early can they undergo best optimal treatment. This presentation was given at the first Monsana Conference in St. Petersburg. Please also check the blog http://www.monsana.net/firstconference

Citation preview

Neonatal Hearing Screening – a short overview of the situation in

Western Europe

Dr. Dr. h.c. Monika Lehnhardt, GermanyMay 2009

Incidence per 10,000 of Congenital Defects/Diseases

30

12 11

6 5 52 1

0

10

20

30

40

Hearing Loss

Cleft lip or palate

Down Syndrome

Limb defects

Spina bifida

Hypothyroidism

Sickle Cell Anemia

PKU

Deafness is not visible

Equipment for Newborn Hearing Screening

Otoacoustic Emissions (OAE)

Automated Auditory Brainstem Response (AABR)

Nucleus® Freedom™ CI System Modern Hearing Aids (e.g. from Phonak)

ECDC- NHSMilan, 15 - 16 May 1998

European Consensus Statement on

Neonatal Hearing Screening

Finalised at the European Consensus Development Conference on Neonatal Hearing Screening

15-16 May 1998, Milan

Chairman: F. Grandori

Germany

>95%

<1%

~40%

?

?

~80%

~55%

~80%

Screening Coverage (2008)

Austria

Belgium

Netherlands

Switzerland

United Kingdom

Poland

Croatia

Spain

“Infants cannot complain of lack of hearing, and cannot seek interventions we would surely not deny ourselves. We can and we must do their complaining for them!”

Dr. Martyn Hyde

http://www.schenken-sie-kindern-gehoer.de

Email: ml@lehnhardt-stiftung.org

http://www.lehnhardt-stiftung.org

Email: m.lehnhardt@t-online.de

Recommended